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Long‑term  pM2.5 exposure 
and the clinical application 
of machine learning for predicting 
incident atrial fibrillation
in‑Soo Kim1,2, Pil‑Sung Yang3, Eunsun Jang1, Hyunjean Jung1, Seng Chan You4, Hee Tae Yu1, 
Tae‑Hoon Kim1, Jae‑Sun Uhm1, Hui‑Nam Pak1, Moon‑Hyoung Lee1, Jong‑Youn Kim2* & 
Boyoung Joung1*
Clinical impact of fine particulate matter  (PM2.5) air pollution on incident atrial fibrillation (AF) had not 
been well studied. We used integrated machine learning (ML) to build several incident AF prediction 
models that include average hourly measurements of  PM2.5 for the 432,587 subjects of Korean general 
population. We compared these incident AF prediction models using c‑index, net reclassification 
improvement index (NRI), and integrated discrimination improvement index (IDI). ML using the 
boosted ensemble method exhibited a higher c‑index (0.845 [0.837–0.853]) than existing traditional 
regression models using  CHA2DS2‑VASc (0.654 [0.646–0.661]),  CHADS2 (0.652 [0.646–0.657]), or 
HATCH (0.669 [0.661–0.676]) scores (each p < 0.001) for predicting incident AF. As feature selection 
algorithms identified  PM2.5 as a highly important variable, we applied  PM2.5 for predicting incident 
AF and constructed scoring systems. The prediction performances significantly increased compared 
with models without  PM2.5 (c‑indices: boosted ensemble ML, 0.954 [0.949–0.959]; PM‑CHA2DS2‑VASc, 
0.859 [0.848–0.870]; PM‑CHADS2, 0.823 [0.810–0.836]; or PM‑HATCH score, 0.849 [0.837–0.860]; 
each interaction, p < 0.001; NRI and IDI were also positive). ML combining readily available clinical 
variables and  PM2.5 data was found to predict incident AF better than models without  PM2.5 or even 
established risk prediction approaches in the general population exposed to high air pollution levels.
Although atrial fibrillation (AF) often leads to complications such as stroke in patients without an awareness of 
such preexisting diseases, electrocardiogram screening is not sufficient to detect AF in the general  population1,2. 
Some scoring systems for predicting incident AF have been introduced, including the  CHADS23,  CHA2DS2-VASc4, 
and  HATCH5 scores; however, their prediction accuracies are not sufficient for wide application. Although epide-
miological studies have suggested that an elevated level of ambient particulate matter < 2.5 μm in aerodynamic 
diameter  (PM2.5) is consistently associated with adverse cardiac  events6 and  arrhythmias7, including  AF8, the 
role of  PM2.5 on incident AF remains to be investigated. Recently, data-driven analyses using machine learning 
(ML) methods have been introduced to identify some blood biomarkers that are risk factors of AF prevalence 
(not incidence)9, and they were considered non-inferior to traditional  analyses9,10. However, it was not clear 
whether these data-driven approaches could find correlations between  PM2.5 and incident AF, or if they could 
predict incident AF better than traditional analysis in clinical practice.
Although some studies from Western countries did not show a correlation between short-term exposure 
to  PM2.5 and incident  AF11,12, the air pollution levels in those areas were much lower than the levels in Asian 
countries; therefore, the effect sizes could be low in those studies. Our previous study, performed in the general 
population of an Asian country, showed correlations between  PM2.5 exposure and increased AF  incidence8. Thus 
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far, the identification of AF risk factors had been hypothesis driven and most studies performed analyses based 
on the selection of several cardiovascular risk factors. To perform a data-driven analysis for revealing AF risk fac-
tors, we used 27 readily available parameters including  PM2.5 level in the Korean general population. All subjects 
without a history of previous AF were included in our population to identify the risk factors for incident AF. We 
also analyzed already revealed clinical risk factors to determine which risk factors best predict incident AF in 
this population. We investigated the robust risk factors for incident AF by using both the traditional regression 
method and the ML algorithm.
Methods
In this nationwide cohort study, we investigated the relationship between long-term exposure to  PM2.5 and inci-
dent AF by using ML methods. The study protocol adhered to the ethical guidelines of the 1975 Declaration of 
Helsinki. The protocol was approved by the Institutional Review Board of Yonsei University College of Medicine, 
which waived the need for informed consent.
Data source. The National Health Insurance Service (NHIS) of Korea is a single-payer program that is 
mandatory for all residents of South Korea. Among the entire South Korean population (about 47 million peo-
ple in 2002), 96.6% are registered in the NHIS. About 70% of the entire cohort had undergone a national health 
examination. This retrospective study used the NHIS-based National Sample Cohort (NSC) 2002–2013 dataset, 
comprising a random sample of 1,025,340 subjects, which amounted to 2.2% of the entire Korean population 
under the NHIS in 2002 (46,605,433). This sample cohort was extracted through probability sampling from all 
beneficiaries of the NHIS and the National Medical Aid in 2002 based on the entirety of the national cohort data. 
Systematic sampling was performed in each of the 1476 strata based on age, sex, eligibility status, socioeconomic 
status, and income level, with the sample size proportionate to the cohort size of the strata. The representative-
ness of the sample has been previously examined by comparing the sample to the entire Korean  population13.
Study cohort. From the NHIS-NSC, adults (n = 506,805) older than 18 years who had undergone a national 
health examination at least once between 2009 and 2013 were  selected13. Each subject was followed from the day 
of the health examination to December 31, 2013, and screened from January 2002 to assess the medical history 
(2002–2008: disease-free baseline period). Each diagnosis, based on the 10th revision of the International Clas-
sification of Disease codes, was defined as the first occurrence during at least two different days of outpatient 
hospital visits or on the first hospital admission (Supplementary Table 1)14,15. The following exclusion criteria 
were applied (Fig. 1): (i) age < 18 years; (ii) a diagnosis of AF before undergoing a health examination; (iii) val-
vular AF, such as mitral valve stenosis or prosthetic valve disease; (iv) change of residence to another ZIP code 
in 2009–2013; and (v) missing data on residential ZIP code or in questionnaires for smoking status and alcohol 
intake completed during the health examinations. A final population of 432,587 subjects was included in the 
analysis (Fig. 1). For the purpose of analysis, the subjects were divided chronologically in an approximately 7:3 
ratio for a conventional discovery-validation approach.
Air pollution measurements. During the study period,  PM2.5 levels, temperature, and humidity were 
measured hourly at the 313 sites of the Korean Nationwide Meteorological Observatory by the Korean Depart-
ment of Environmental Protection. The entire Korean peninsula is divided into 256 residential ZIP codes includ-
ing 74 metropolitan areas (average 73 km2). To assess long-term  PM2.5 exposure effects, the nearest monitoring 
facility of each residence was identified and used to assess the average annual pollutant levels for each study 
 subject16. The geographically based long-term average  PM2.5 level during the study period was measured hourly 
by the monitoring  facilities16, and 256 residential ZIP codes were matched with the nearest monitoring facilities. 
Meteorological variables (temperature and humidity) were included as geographically based long-term averages 
of the hourly measured temperature and humidity for each subject during the follow-up period. The long-term 
average (during the total study period for each subject)  PM2.5 levels and meteorological measurements (tempera-
ture and humidity) were calculated from these hourly measurements at each site. The Korean National Ambient 
Air Quality Standards (NAAQS) and  PM2.5 measurement methods are described in Supplementary Table 2.
Primary outcome. The primary outcome was the incidence of AF according to the  PM2.5 level. AF was 
diagnosed on the basis of hospital admission or at least two outpatient visits for  AF17,18. The cohort was followed 
up to the time of an AF incident, the time of disqualification from the NHIS (death or immigration), or the end 
of the study (December 31, 2013).
Machine learning. Twenty-six readily available clinical parameters and  PM2.5 data were used for variable 
selection. Several supervised ML classifiers included support vector machine (SVM), decision tree, random 
forest, Naïve Bayes, deep neural network, and extreme gradient boosting models. Our SVM model was used to 
differentiate patients whether they developed new-onset AF or not by a computed hyper-plane (the optimal cost 
and gamma parameters were found with radial kernel) which separates these categories most  effectively19. Our 
decision tree model constructed with a recursive tree structure using computationally selected parameters can 
differentiate features step by step by creating appropriate splits (recursive partitioning). And it was combined 
by ensembled algorithms to construct better prediction models such as gradient boosting (500 iterations using 
root mean square error as evaluating metric) and random forest (ten decision trees were combined to construct 
the best model)20. As mathematical models, artificial neural network systems mimic human neural networks 
which can be trained to discriminate different patterns of diseases, and we selected the three-layered deep neural 
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network model using Tensorflow backend with Keras  framework21. The entire ML process consisted of ML with 
automated feature selection by information gain attributive ranking  algorithm22, model constructing with a 
boosted ensemble algorithm, and tenfold cross-validation to reduce  overfitting23.
On the basis of supervised ML methods to construct prediction models, we used a sequential method of 
feature construction and automated selection by information gain ranking to identify predictive risk factors 
from the various health examination  parameters22. Variable selection with an entry criterion of p < 0.05 was 
applied, and data-driven approaches were used to identify the smallest number of variables required for each 
prediction model. By using each model, selected variables including  PM2.5 were modeled for their association 
with incident AF in the discovery cohort, and subsequently evaluated in the validation cohort (Fig. 1). New-onset 
AF events were analyzed with the geographically based long-term average  PM2.5 level during the study period 
for each subject. Bootstrapping and tenfold cross-validation were used to adjust the model coefficient to avoid 
overfitting in the discovery sample. Model accuracy was calculated in the validation sample (30% of the original 
dataset), and loss was calculated using binary or categorical cross-entropy. The area under the receiver operating 
characteristic curve or c-index was used for each constructed model, and the net reclassification improvement 
index (NRI) and integrated discrimination improvement index (IDI) were calculated to assess the additional 
discriminative ability of these models.
Networks for training and validation were constructed based on Tensorflow (version 1.10) using the Keras 
framework (version 2.1.6), and all statistical analyses were performed using R (version 3.5) and Python (version 
3.6) software. Training and validation were performed on an Intel central processing unit Xeon Scalable Gold 
6126 under two graphics processing unit (GPU) devices support (two Nvidia RTX 2080Ti GPU devices; CUDA 
version 9.0), and constructed models were saved for further analysis.
Statistical analyses. The baseline characteristics of subjects with and without AF in both the discovery and 
validation cohorts were compared. We assumed that the study subjects were exposed to ambient air pollution 
within their residential ZIP codes during the study  period16. Individual subjects were matched with the average 
air pollution levels and meteorological information during the study period obtained from the nearest monitor-
ing facilities (according to the subjects’ residential address). By using Cox proportional-hazard model regression 
Figure 1.  Study cohort and included subjects from the National Health Insurance Service National Sample 
Cohort (NHIS-NSC; overall general population). We randomly divided the population into the discovery 
(n = 302,811) and validation (n = 129,776) cohorts. In the discovery cohort, model construction and training 
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analysis, the relationship between incident AF and  PM2.5 level was analyzed using a generalized estimating equa-
tion approach with a random-effect  analysis24. The proportionality of the hazard assumptions was checked with 
a log-minus-log graph and a test on the Schoenfeld residuals. Consequently, the test results were found to be 
valid for each lifestyle factor. In Cox regression analysis, the included subjects were followed from their national 
health examination until the development of new-onset AF, disqualification (death or immigration), or the end 
of the study. A two-tailed p-value of < 0.05 was considered statistically significant.
Results
Baseline characteristics. There were no significant differences in body mass index (BMI), smoking his-
tory, socioeconomic status, and follow-up duration between the groups (Table 1). Subjects who developed new-
onset AF during the follow-up were older, included a higher proportion of men, were more likely to have comor-
bidities, and were exposed to higher average  PM2.5 levels than those without AF (Table 1). Subjects with AF had 
higher use of antiplatelet agents, beta-blockers, and statins than those without AF.
Application of  PM2.5 to traditional regression analysis improves the prediction of incident 
AF. The air pollution and meteorological measurements are described in detail in Supplementary Results 
(Supplementary Table 3). We have previously reported on the association between increased exposure to long-
term average  PM2.5 and increased incidence of  AF8. The traditional regression analysis with a forward selection 
method revealed  PM2.5 and the following seven clinical risk factors to be associated with incident AF: older age 
(odds ratio [OR] 1.06 [1.05–1.07] per year increase, p < 0.001), male sex (OR 1.57 [1.42–1.73], p < 0.001), higher 
BMI (OR 1.04 [1.02–1.05] per 1  kg/m2 increase, p < 0.001), higher diastolic blood pressure (OR 1.05 [1.03–
1.8] per 5 mmHg increase, p = 0.013) and systolic blood pressure (OR 1.02 [1.01–1.04] per 5 mmHg increase, 
p = 0.034), history of previous heart failure (OR 2.20 [1.90–2.54], p < 0.001), lower serum estimated glomerular 
filtration rate (OR 1.04 [1.02–1.07] per 10 mL/min decrease, p < 0.001), and higher level of  PM2.5 exposure (OR 
1.27 [1.24–1.31] per 10 μg/m3 increase, p < 0.001). After the application of  PM2.5 to the readily available clini-
cal risk factors, the c-index of the model for predicting incident AF was improved from 0.643 (0.636–0.649) 
to 0.819 (0.813–0.825) (p < 0.001) (Table 2). The NRI and IDI between these models were also positive (1.069 
[1.038–1.103] and 0.302 [0.294–0.322], respectively) (Table 2).
Risk factors including  PM2.5 for incident AF and score development. Crude and multivariable-
adjusted Cox regression analyses showed that heart failure, hypertension, age (≥ 75 years), diabetes, previous 
stroke/transient ischemic attack, previous myocardial infarction or peripheral vascular disease, male sex, chronic 
obstructive pulmonary disease (these are components of the  CHA2DS2-VASc,  CHADS2, and HATCH scores), 
and  PM2.5 (≥ 15 μg/m3 based on the Korean annual NAAQS)25 were independent risk factors for incident AF 
(Table 3). According to these multivariable Cox regression analyses,  PM2.5 ≥ 15 μg/m3 (HRs 1.1–1.4) was pointed 
as 1 compared with HRs of other clinical variables and added this to existing  CHA2DS2-VASc,  CHADS2, and 
HATCH systems, then we developed new simple PM-CHA2DS2-VASc, PM-CHADS2, and PM-HATCH scores 
(Table 3). The total scores ranged from 0 to 10, 0 to 7, and 0 to 8 points, respectively.
The scores showed good discrimination with c-indices of 0.859 (0.848–0.870), 0.823 (0.810–0.836), and 
0.849 (0.837–0.860), respectively (Table 2). These scoring systems showed significantly better performances for 
predicting incident AF than each existing score  (CHA2DS2-VASc,  CHADS2, and HATCH), and their NRI and 
IDI were also positive (Table 2).
Incidence rates of AF and the PM‑CHA2DS2‑VASc, PM‑CHADS2, and PM‑HATCH scores. Sup-
plementary Table 4 shows the annual incidence rates (%/year) and hazard ratios at each point of these scoring 
systems. We divided the overall population into three groups according to each score: low risk (0–1 point; 0.13%/
year by PM-CHA2DS2-VASc score, 0.11%/year by PM-CHADS2 score, and 0.17%/year by PM-HATCH score), 
intermediate risk (2–3 points; 1.30%/year by PM-CHA2DS2-VASc score, 0.70%/year by PM-CHADS2 score, and 
1.75%/year by PM-HATCH score), and high risk (≥ 4 points; 2.74%/year by PM-CHA2DS2-VASc score, 2.05%/
year by PM-CHADS2 score, and 3.51%/year by PM-HATCH score). Kaplan–Meier curves showed consistent 
findings according to risk categories (log-rank p < 0.001, Fig. 2).
Comparing ML models with the traditional regression model. To estimate the crude accuracies 
of the ML models for predicting incident AF, we compared the six ML models and the traditional regression 
analysis model with age, sex, and BMI as input variables (Table 4). The c-indices of the six ML models (SVM, 
decision tree, random forest, naïve Bayes, deep neural network, and extreme gradient boosting models) were 
0.699 (0.688–0.710), 0.786 (0.771–0.800), 0.787 (0.772–0.801), 0.794 (0.780–0.807), 0.779 (0.768–0.790), and 
0.790 (0.776–0.805), respectively, and they were all significantly better than the c-index of the traditional regres-
sion analysis model (c-index 0.604 [0.598–0.611], all p < 0.001). All NRI and IDI were also positive (Table 4). The 
extreme gradient boosting model showed the highest c-index for predicting incident AF among these models 
(Table 4).
Validation by ML models and the application of  PM2.5 for predicting incident AF. We used sev-
eral ML models and performed analyses for predicting incident AF in our cohort. We used the 27 variables listed 
in Table 1 as input variables for the ML models and performed training using a discovery cohort of 302,811 
subjects including 2444 with incident AF (0.8%) that developed over the 5-year follow-up period (Table 1). The 
feature selection process revealed variables that were most relevant for building the ML models (Supplementary 
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Figure or Variable importance 10 ranking—Table  5). For random forest and extreme gradient boosting ML 
models, based on decision trees, the rank variable importance is determined by the selection frequency of the 
variables as a decision node, whereas SVM uses the sensitivity of generalization error bounds with respect to 
a variable and neural networks use overall weighting of the variable within the  model26.  PM2.5 was also highly 
ranked and other variables were also selected, as described in Supplementary Figure and Table 5.
After applying the tenfold cross-validation algorithm, the best ML model was the extreme gradient boosting 
model of the boosted ensemble algorithm with a c-index of 0.845 (0.837–0.853) (Table 2). After adding  PM2.5 as 
Table 1.  Baseline characteristics of the study population (n = 432,587). AF atrial fibrillation, BMI body mass 
index (kg/m2), CKD chronic kidney disease (eGFR lower than 60 mL/min estimated by serum creatinine 
using CKD-EPI formula)37, COPD chronic obstructive pulmonary disease, DBP diastolic blood pressure, eGFR 
estimated glomerular filtration rate (mL/min), HDL high density lipoprotein, LDL low density lipoprotein, MI 
myocardial infarction, PM2.5 particulate matter < 2.5 μm in diameter, SBP systolic blood pressure, TIA transient 
ischemic attack. *Socioeconomic status was divided into two groups: higher (≥ 51% of income level) and lower 
(< 51% of income level).
Variables
Discovery Validation
No AF (n = 300,367) Incident AF (n = 2,444) No AF (n = 126,395) Incident AF (n = 3,381)
Age, years 48.3 ± 14.1 63.1 ± 13.4 45.7 ± 14.5 62.8 ± 12.4
65–74 (%) (11.3) (30.3) (7.5) (35.2)
≥ 75 (%) (3.2) (19.6) (3.4) (15.0)
Male (%) (50.5) (53.2) (46.9) (57.6)
BMI, kg/m2 23.7 ± 3.2 24.2 ± 3.4 23.6 ± 3.5 24.3 ± 3.4
Obesity (BMI ≥ 27.5 kg/m2) (%) (11.8) (15.6) (12.8) (16.1)
Smoking, pack·years 6.1 ± 11.8 8.1 ± 15.3 5.8 ± 11.4 8.8 ± 15.8
Non- (%) (62.6) (63.4) (62.0) (61.8)
< 20 pyrs (%) (24.3) (17.6) (25.5) (17.6)
≥ 20 pyrs (%) (13.1) (19.0) (12.5) (20.6)
Alcohol intake, g/week (mean) 61.2 ± 13.7 45.9 ± 12.7 63.9 ± 14.4 55.8 ± 15.1
≥ 220.5 g/week (7.8) (6.3) (8.3) (7.7)
Socioeconomic status, higher* (%) (60.9) (62.6) (59.3) (62.2)
Hypertension (%) (22.0) (72.2) (19.4) (68.1)
SBP (mmHg) 122.4 ± 15.2 126.5 ± 16.5 121.4 ± 15.4 127.1 ± 16.3
DBP (mmHg) 76.2 ± 10.1 77.4 ± 10.9 75.6 ± 10.3 78.0 ± 10.4
Diabetes (%) (6.1) (19.1) (6.2) (17.8)
Fasting blood glucose (mg/dL) 97.6 ± 24.0 105.7 ± 32.8 97.8 ± 25.6 103.8 ± 29.6
CKD (%) (6.3) (18.8) (4.0) (20.6)
eGFR (mL/min) 88.0 ± 21.3 77.2 ± 21.7 93.4 ± 19.9 75.5 ± 21.2
Dyslipidemia (%) (18.9) (54.5) (19.7) (46.5)
Total cholesterol (mmol/L) 195.4 ± 37.0 185.6 ± 38.8 193.3 ± 37.2 190.3 ± 39.1
Triglyceride (mmol/L) 131.8 ± 90.2 131.4 ± 78.3 124.9 ± 84.3 138.4 ± 84.9
HDL cholesterol (mmol/L) 56.1 ± 25.7 53.1 ± 24.6 56.3 ± 17.9 55.2 ± 38.2
LDL cholesterol (mmol/L) 114.2 ± 38.0 107.3 ± 37.0 112.4 ± 34.3 109.8 ± 37.5
Previous MI (%) (0.9) (9.9) (0.9) (7.7)
Peripheral vascular disease (%) (3.1) (19.4) (3.2) (15.1)
Heart failure (%) (2.1) (27.5) (2.1) (23.0)
Previous stroke/TIA (%) (3.6) (20.6) (3.6) (17.3)
COPD (2.2) (10.7) (2.3) (9.8)
Other blood test results
Hemoglobin (g/dL) 13.9 ± 1.6 13.7 ± 1.8 13.9 ± 1.7 13.8 ± 1.7
Aspartate transaminase (IU/L) 25.3 ± 16.3 27.1 ± 15.5 24.9 ± 17.1 27.8 ± 17.8
Alanine transaminase (IU/L) 25.0 ± 21.7 24.4 ± 20.2 24.1 ± 22.4 25.5 ± 18.9
Gamma-glutamyl transferase (U/L) 36.0 ± 49.3 45.7 ± 72.9 36.0 ± 53.9 46.4 ± 67.9
Medications at enrollment
Antiplatelet agent (%) (9.7) (49.2) (8.7) (44.5)
Beta-blocker (%) (7.5) (40.0) (6.7) (34.2)
Statin (%) (8.1) (29.9) (8.3) (23.3)
Average  PM2.5 concentration (μg/m3) 18.5 32.7 18.5 35.7
Total follow-up year 3.8 3.9 3.8 3.9
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an input variable, the performance of predicting incident AF was improved, with a c-index of 0.954 (0.949–0.959) 
with NRI of 1.277 (1.218–1.334) and IDI of 0.461 (0.438–0.485) (Table 2). For models using SVM, decision tree, 
random forest, naïve Bayes, and deep neural network algorithms, the performances for predicting incident AF 
were significantly improved after applying  PM2.5, with c-indices of 0.903 (0.895–0.910), 0.931 (0.925–0.937), 
0.939 (0.933–0.945), 0.894 (0.888–0.900), and 0.849 (0.834–0.865), respectively (Fig. 3 and Table 2). All NRI 
and IDI were also positive (Table 2).
Discussion
There have been few studies about the correlations between  PM2.5 and incident AF, and the clinical significance 
of  PM2.5 for predicting AF incidence has not been investigated. In this study, we investigated the clinical impact 
of  PM2.5 on predicting AF incidence by using ML methods in the general population of an Asian country affected 
by high air pollution levels. ML methods identified the clinically important variables for predicting incident AF, 
and  PM2.5 was also identified as a highly ranked important variable. With the addition of the  PM2.5 variable, 
the prediction performance significantly improved with both traditional regression analysis and ML methods. 
Additionally, based on traditional regression analysis, we constructed scoring systems for predicting incident 
Table 2.  Performance of predictive models for incident AF risk during follow-up period in overall general 
population. AF atrial fibrillation, BMI body mass index, CI confidence interval, DBP diastolic blood pressure, 
eGFR estimated glomerular filtration rate, HF heart failure, IDI integrated discrimination improvement index, 
NRI category-free net reclassification improvement index, PM2.5 particulate matter < 2.5 μm in diameter, SBP 
systolic blood pressure, TR traditional regression analysis. *TR1 (model 1), clinical 6 variables (age, sex, BMI, 
SBP, previous HF history, and serum eGFR) -adjusted c-index; TR2 (model 2), clinical 12 variables (age, sex, 
BMI, SBP, diabetes, previous HF history, previous stroke/TIA history, previous myocardial infarction history, 
serum eGFR, serum total cholesterol, smoking history, and alcohol intake habit) -adjusted c-index. DBP was 
not included in these models because of multicollinearity with SBP. † Clinical 6 variables (*) plus  PM2.5-adjusted 
c-index. ‡ We pointed as 1 if  PM2.5 ≥ 15 μg/m3 based on Korean National Ambient Air Quality Standards 
and added this PM score to established  CHADS2,  CHA2DS2-VASc, and HATCH scores as PM-CHADS2, 
PM-CHA2DS2-VASc, PM-HATCH  scores25.
Models c-index (95% CI) NRI IDI
Traditional regression analysis (TR)
Clinical variables-adjusted (TR1, model 1)* 0.643 (0.636–0.649) Ref Ref
 TR1 plus  PM2.5-adjusted (model 1)† 0.819 (0.813–0.825) 1.069 (1.038–1.103) 0.302 (0.294–0.322)
Clinical variables-adjusted (TR2, model 2)* 0.684 (0.675–0.693) Ref Ref
 TR2 plus  PM2.5-adjusted (model 2)† 0.869 (0.862–0.876) 1.087 (1.060–1.113) 0.219 (0.209–0.228)
CHA2DS2-VASc score 0.654 (0.646–0.661) Ref Ref
 PM-CHA2DS2-VASc  score‡ 0.859 (0.848–0.870) 1.078 (1.059–1.102) 0.220 (0.208–0.233)
CHADS2 score 0.652 (0.646–0.657) Ref Ref
 PM-CHADS2  score‡ 0.823 (0.810–0.836) 0.981 (0.962–1.001) 0.042 (0.029–0.054)
HATCH score 0.669 (0.661–0.676) Ref Ref
 PM-HATCH  score‡ 0.849 (0.837–0.860) 1.004 (0.983–1.024) 0.053 (0.042–0.064)
Machine learning models
Support vector machine
 Clinical variables-adjusted* 0.766 (0.757–0.775) Ref Ref
  Clinical variables plus  PM2.5-adjusted† 0.903 (0.895–0.910) 1.061 (1.038–1.083) 0.270 (0.260–0.281)
Decision tree
 Clinical variables-adjusted* 0.801 (0.787–0.815) Ref Ref
  Clinical variables plus  PM2.5-adjusted† 0.931 (0.925–0.937) 1.054 (1.027–1.081) 0.265 (0.256–0.275)
Random forest
 Clinical variables-adjusted* 0.838 (0.830–0.846) Ref Ref
  Clinical variables plus  PM2.5-adjusted† 0.939 (0.933–0.945) 1.027 (1.006–1.050) 0.242 (0.232–0.253)
Naïve Bayes
 Clinical variables-adjusted* 0.833 (0.825–0.841) Ref Ref
  Clinical variables plus  PM2.5-adjusted† 0.894 (0.888–0.900) 0.987 (0.959–1.014) 0.152 (0.142–0.162)
Deep neural network
 Clinical variables-adjusted* 0.813 (0.800–0.826) Ref Ref
  Clinical variables plus  PM2.5-adjusted† 0.849 (0.834–0.865) 0.792 (0.745–0.837) 0.088 (0.074–0.101)
Extreme gradient boosting
 Clinical variables-adjusted* 0.845 (0.837–0.853) Ref Ref
  Clinical variables plus  PM2.5-adjusted† 0.954 (0.949–0.959) 1.277 (1.218–1.334) 0.461 (0.438–0.485)
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AF by adding the  PM2.5 variable to existing risk prediction systems: PM-CHA2DS2-VASc, PM-CHADS2, and 
PM-HATCH, which showed better predicting performances than the established scoring systems.
Although some studies, including our previous  study8, have shown the relationships between air pollution 
exposure and AF development in patients with known cardiac  diseases27, some studies from Western countries 
did not show a relationship between  PM2.5 exposure and incident  AF11,12. However, these studies were performed 
in European countries and the United States, where the air pollution levels were much lower than the levels in 
Asian countries. Therefore, the effect sizes could be low in those studies. In our nationwide dataset, to facilitate 
the data-driven analysis for revealing AF risk factors, we used 27 readily available parameters among the general 
population, and  PM2.5 was identified as a highly ranked variable. Adding the information of  PM2.5 exposure to 
known clinical risk factors can enable a better prediction of incident AF in the general population. Addition-
ally, we attempted to apply this information about  PM2.5 exposure for predicting incident AF in clinical practice 
by constructing relevant risk scores based on the Korean NAAQS, which might add some information when 
managing patients with AF risk factors. Further prospective studies using these new risk scoring systems will 
be needed whether upstream medical therapy is beneficial to prevent incident AF in the general population.
The adverse health effects related to air pollution have been studied since  199328, even for  arrhythmias29. One 
suggested mechanism is the occurrence of myocardial repolarization abnormalities contributing to  arrhythmias30 
caused by systemic inflammatory cytokines produced by pulmonary inflammatory responses after inhaling 
Table 3.  Association of  PM2.5 with the incidence of AF in overall general population. AF atrial fibrillation, 
CI confidence interval, HR hazard ratio, PM2.5 particulate matter < 2.5 μm in diameter, TIA transient ischemic 
attack. *Unadjusted Cox proportional hazards model. † Cox proportional hazards model adjusted for clinical 
variables. Clinical variables were remaining  CHA2DS2-VASc,  CHADS2, and HATCH components of age, male 
sex, heart failure, hypertension, diabetes, stroke/transient ischemic attack, vascular disease including previous 
history of myocardial infarction or peripheral vascular disease, and chronic obstructive pulmonary disease. 
‡ In these Cox proportional hazards models,  PM2.5 variable was analyzed as categorical variable with dividing 
subjects into subgroups as  PM2.5 ≥ 15 μg/m3 or < 15 μg/m3 based on the Korean National Ambient Air Quality 
 Standards25. § Age variable was analyzed as binary or three categorical variables with dividing subjects into 
subgroups as: (for binary categorical variables) age ≥ 75 or < 75 years; or (for three categorical variables) age 
≥ 75, 65–74, or < 65 years. || p-value < 0.001.
Variables
Crude*
Adjusted for clinical  variables† including 
 CHA2DS2-VASc score components plus 
 PM2.5
Adjusted for clinical  variables† including 
 CHADS2 score components plus  PM2.5
Adjusted for clinical  variables† including 
HATCH score components plus  PM2.5
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
PM2.5 (≥ 15 μg/m3)‡ 1.439 (1.231–1.623) || 1.248 (1.103–1.384) || 1.186 (1.122–1.251) || 1.329 (1.189–1.466) ||
Age §
≥ 75 years 6.548 (5.995–7.152) || 2.167 (1.915–2.444) || 2.115 (1.873–2.381) ||
65–74; ≥ 75 years 5.670 (5.262–6.109) || 3.402 (3.127–3.701) ||
Male sex 1.352 (1.263–1.447) || 1.634 (1.526–1.750) ||
Heart failure 6.775 (6.124–7.494) || 2.013 (1.806–2.243) || 2.102 (1.885–2.343) || 2.612 (2.403–2.846) ||
Hypertension 5.196 (4.855–5.560) || 1.743 (1.524–1.980) || 1.931 (1.638–2.247) || 2.074 (1.778–2.392) ||
Diabetes 3.178 (2.908–3.473) || 1.310 (1.202–1.430) || 1.364 (1.241–1.498) ||
Stroke/TIA 4.368 (3.965–4.812) || 2.282 (2.156–2.422) || 2.495 (2.348–2.659) || 2.503 (2.355–2.667) ||
Vascular disease 3.491 (3.081–3.955) || 1.285 (1.142–1.449) ||
COPD 4.445 (3.954–4.997) || 1.780 (1.574–2.014) ||
Figure 2.  Kaplan–Meier curves for risk categories according to PM-CHA2DS2-VASc, PM-CHADS2, and 
PM-HATCH scores. Patients were divided into three groups as low (0–1 points), intermediate (2–3 points), 
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 particles6. Another suggested mechanism includes alteration of the cardiac autonomic nervous system that 
occurs with the inhalation of particles mediated by reactive oxygen  species31,32, these adverse inhalation effects 
can be diminished in patients with chronic lung parenchymal  diseases33,34.
As an advanced computing technology for artificial intelligence, ML is increasingly used in cardiology to 
meaningfully process data that exceed the capacity of the human  brain35. Unlike traditional statistical analyses, 
ML models can accept enormous data as input variables and can improve the prediction performances through 
a repetitive training process, thus offering more applicable prediction models to external  datasets20,36. Everyone 
can access this advanced computing technology and it can rapidly construct models by automatically training 
process, consequently it can offer better prediction model than traditional model manually made by  human35. 
However, ML is highly data-dependent (“garbage-in, garbage-out”) and hard to interpret, and it often develops 
overfitting  problems35.
To the best of our knowledge, this is the first cohort study with 1,666,528 person-years of follow-up to assess 
the prediction performance of long-term  PM2.5 exposure for incident AF. Additionally, long-term  PM2.5 exposure 
was identified as a highly important variable for predicting incident AF by using ML methods. After adding 
the  PM2.5 variable to established AF prediction scoring systems, the prediction performances for incident AF 
significantly improved.
Our study suggests that applying long-term average  PM2.5 measurements in clinical practice could better 
predict the development of AF in patients. Additionally, ML using boosted ensemble methods can predict inci-
dent AF better, with readily available subject characteristics, than traditional regression analysis. The detailed 
characteristics of the subjects in this study allowed blood pressure measurements, blood test results including 
fasting glucose and cholesterol profiles, and smoking and alcohol intake habits to be integrated in these analyses.
On the basis of these findings, we constructed scoring systems for predicting incident AF by adding the  PM2.5 
variable to existing risk prediction approaches: PM-CHA2DS2-VASc, PM-CHADS2, and PM-HATCH, which 
showed better predicting performances than established scoring systems.
Table 4.  Performance of predictive models for incident AF risk during follow-up period in overall general 
population (age, sex, and BMI-adjusted models). AF atrial fibrillation, BMI body mass index, CI confidence 
interval, IDI integrated discrimination improvement index, NRI category-free net reclassification improvement 
index. *Age, sex, and BMI were used for constructing these predictive models (age, sex, and BMI were adjusted 
for traditional regression analysis, and these variables were used as input variables for training the listed 
machine learning models).
Predictive models* c-index (95% CI) NRI (95% CI) IDI (95% CI)
Traditional regression analysis 0.604 (0.598–0.611) Ref Ref
Machine learning models
Support vector machine 0.699 (0.688–0.710) 0.280 (0.220–0.340) 0.002 (0.001–0.003)
Decision tree 0.786 (0.771–0.800) 0.806 (0.747–0.866) 0.010 (0.009–0.011)
Random forest 0.787 (0.772–0.801) 0.764 (0.701–0.827) 0.006 (0.005–0.007)
Naïve Bayes 0.790 (0.776–0.805) 0.792 (0.732–0.853) 0.009 (0.008–0.010)
Deep neural network 0.779 (0.768–0.790) 0.218 (0.182–0.253) 0.002 (0.001–0.003)
Extreme gradient boosting 0.794 (0.780–0.807) 0.536 (0.484–0.589) 0.005 (0.004–0.006)
Table 5.  Ranking of the 10 most important variables for algorithms run for predicting incident AF (among 
27 clinical variables). AF atrial fibrillation, BMI body mass index, CI confidence interval, eGFR estimated 
glomerular filtration rate (mL/min), HDL high density lipoprotein, HR hazard ratio, LDL low density 





Support vector machines 
with linear Kernel Decision tree Random forest
Extreme gradient 
boosting
1 Heart failure Heart failure Age Serum eGFR Heart failure
2 Systolic blood pressure Systolic blood pressure Serum eGFR Systolic blood pressure Systolic blood pressure
3 Age Age Heart failure Age Age
4 Previous ischemic stroke/TIA Previous ischemic stroke/TIA Systolic blood pressure Heart failure PM2.5
5 PM2.5 PM2.5 Previous ischemic stroke/TIA PM2.5 Serum triglyceride
6 Serum eGFR Serum eGFR PM2.5 Sex Serum total cholesterol
7 Serum triglyceride Previous MI Serum triglyceride BMI Serum HDL cholesterol
8 Sex Sex Sex Smoking history BMI
9 Smoking history Smoking history Smoking history Fasting blood glucose Serum eGFR
10 Serum total cholesterol BMI BMI Previous ischemic stroke/TIA Serum LDL cholesterol
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Although our findings from traditional regression analysis and novel ML methods drew similar results, there 
are some limitations. Although we set disease-free baseline period (7 years: 2002–2008) with excluding subjects 
with a previous AF history, the existence of selection bias cannot be ruled out. However, the diagnostic accuracy 
of AF with this manner was previously validated in our NHIS  database17. Although we excluded subjects who 
changed residence within the study period, subjects’ air pollutant exposure or specific locations could not be 
fully reflected during the period. In addition, as our data were from the National Health Insurance administrative 
claims database, the exact hour of AF development could not be identified. Therefore, we thought that the analysis 
for the effects of acute exposure might draw somewhat biased results, and further investigations are  needed8. 
Although we used previously established risk scoring systems such as  CHA2DS2-VASc4,  CHADS23, and  HATCH5 
scores, they were not originally designed for predicting incident AF. However, these scores included important 
clinical comorbidities affect AF development, and we also assessed the prediction performances of traditional 
regression analyses and ML methods using readily available clinical risk factors and it showed better prediction 
performances with  PM2.5 than those without  PM2.5 (Table 2 and Fig. 3). Our prediction models did not adjust 
some confounders such as echocardiographic parameters (left atrial size, left ventricular ejection fraction, and 
ventricular chamber size), other chronic diseases (liver diseases, dementia, and chronic systemic inflammatory 
diseases), and some exposure confounders (occupational aspects who usually work inside or outside) that affect 
AF development or air pollution exposures. As we did not investigate the associations between air pollution 
and myocardial repolarization or inflammatory markers, the mechanism behind the relationship of exposure to 
air pollution and AF remains unclear. Although statistical approaches including cross-validation to minimize 
overfitting were applied when constructing ML models, and they supported our main results, external validation 
is needed especially in Western countries where the air pollution level is low.
Figure 3.  Comparison of models for predicting incident atrial fibrillation based on the c-index. DNN deep 
neural network model, DT decision tree model, NB naïve Bayes model, PM2.5 particulate matter < 2.5 μm in 
diameter, RF random forest model, SVM support vector machine, TR1 traditional regression analysis model 
using clinical six variables (adjusted variables were same with that of TR1 (model 1) in Table 2) as input 
variables, TR2 traditional regression analysis model using clinical 12 variables (adjusted variables were same 
with that of TR2 (model 2) in Table 2), XGBM extreme gradient boosting model.
10
Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:16324  | https://doi.org/10.1038/s41598-020-73537-8
www.nature.com/scientificreports/
conclusions
Data-driven approaches suggested long-term exposure to  PM2.5 air pollution as a risk factor robustly associated 
with incident AF. Such ML models combining readily available clinical characteristics and  PM2.5 measurements 
were found to predict incident AF better than traditional statistical models or even established risk prediction 
approaches in the Korean general population exposed to high levels of air pollution. Further external validation 
is warranted especially in Western countries affected by low levels of air pollution.
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